Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Proof-of-concept Study of APD421

This study has been completed.
Information provided by (Responsible Party):
Acacia Pharma Ltd Identifier:
First received: February 24, 2011
Last updated: September 21, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)